International clinical experience with a new low-dose, Monophasic oral contraceptive containing levonorgestrel 100 μg and ethinyl estradiol 20 μg

This publication has 10 references indexed in Scilit:

• An open-label, multicenter, noncomparative safety and efficacy study of Mircette™, a low-dose estrogen-progestin oral contraceptive
  American Journal of Obstetrics and Gynecology, 1998
• A multicenter, uncontrolled clinical investigation of the contraceptive efficacy, cycle control, and safety of a new low dose oral contraceptive containing 20 μg ethinyl estradiol and 100 μg levonorgestrel over six treatment cycles
  Contraception, 1997
• Modern oral contraceptives and cardiovascular disease
  American Journal of Obstetrics and Gynecology, 1997
• A twelve-month comparative clinical investigation of two low-dose oral contraceptives containing 20 μg ethinylestradiol/75 μg gestodene and 30 μg ethinylestradiol/75 μg gestodene, with respect to efficacy, cycle control, and tolerance
  Contraception, 1997
• A new low-dose monophasic combination oral contraceptive (Alesse™) with levonorgestrel 100 μg and ethinyl estradiol 20 μg
  Contraception, 1997
• Inhibition of ovulation by an oral contraceptive containing 100 μg levonorgestrel in combination with 20 μg ethinylestradiol
  Contraception, 1996
• Clinical comparison of two low-dose oral contraceptives, Minulet® and Mercilon®, in women over 30 years of age
  Contraception, 1994
• Oral contraceptives and cycle control: A critical review of the literature
  Advances in Contraception, 1992
• The Evolution of Oral Contraceptives: Maximizing Efficacy, Minimizing Risks
  Acta Obstetricia et Gynecologica Scandinavica, 1990
• STATISTICAL EVALUATION OF CONTRACEPTIVE METHODS
  Clinical Obstetrics and Gynecology, 1974